Tectonic Therapeutic, Inc. SEC filings TECX
Tectonic Therapeutic, Inc. has 582 filings in SEC EDGAR's recent list, going back to Aug 3, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 10, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 23, 2026 | Apr 23, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 17, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 30, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 19, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 5, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Other events
|
Jun 4, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 30, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Regulation FD disclosure
|
Jan 30, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jul 12, 2023 | Jul 6, 2023 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Jun 14, 2023 | May 19, 2023 |
| 8-K |
Current report
Other events
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
Jun 12, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Regulation FD disclosure
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 18, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 1, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Feb 27, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 7, 2022 | Oct 4, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 29, 2022 | Jun 27, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2022 | May 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2022 | May 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2022 | May 17, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jan 7, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Other events
|
Jan 4, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 19, 2021 | Oct 19, 2021 |
| 8-K |
Current report
Other events
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Other events
|
Jun 17, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Other events
|
May 3, 2021 | May 3, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 8, 2021 | Feb 8, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2020 | Nov 19, 2020 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 21, 2020 | Oct 19, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2020 | Oct 6, 2020 |
| 8-K |
Current report
Other events
|
Oct 5, 2020 | Oct 5, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Other events
|
Jul 6, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 13, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Other events
|
Feb 10, 2020 | Feb 10, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jul 17, 2019 | Jul 16, 2019 |
| 8-K |
Current report
Other events
|
Jul 15, 2019 | Jul 15, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2019 | Jun 11, 2019 |
| 8-K |
Current report
Results of operations
|
May 13, 2019 | May 13, 2019 |
| 8-K |
Current report
Other events
|
Apr 29, 2019 | Apr 29, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2019 | Mar 25, 2019 |
| 8-K |
Current report
Other events
|
Feb 6, 2019 | Feb 6, 2019 |
| 8-K |
Current report
Other events
|
Jan 22, 2019 | Jan 17, 2019 |
| 8-K/A |
Amended current report
Officer or director change
|
Jan 11, 2019 | Dec 17, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2019 | Jan 5, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 21, 2018 | Dec 17, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2018 | Nov 13, 2018 |
| 8-K |
Current report
Other events
|
Oct 1, 2018 | Oct 1, 2018 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2018 | Sep 21, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2018 | Aug 9, 2018 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jun 25, 2018 | Jun 20, 2018 |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1681087
- Former names
- AvroBio, Inc. (until Jun 18, 2024); AVROBIO, Inc. (until Jun 18, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.